10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 314 filers reported holding 10X GENOMICS INC in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $3,335,000 | -82.0% | 43,845 | -64.3% | 0.01% | -80.8% |
Q4 2021 | $18,548,000 | +27.0% | 122,932 | +22.6% | 0.03% | +13.0% |
Q3 2021 | $14,601,000 | -53.8% | 100,296 | -37.8% | 0.02% | -54.9% |
Q2 2021 | $31,611,000 | +176.2% | 161,199 | +155.0% | 0.05% | +142.9% |
Q1 2021 | $11,444,000 | – | 63,225 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |